Dr Moore is a Reader in Global Health and Infectious Diseases, funded by the Wellcome Trust and Fleming Fund. She works in a multi-disciplinary team and has an interest in drug-resistant infections, with a particular focus on data and interventions to reduce the burden of antibiotic resistance. Her focus is on antimicrobial resistance (AMR) in the community. She is involved in global and regional dialogues around the increase of AMR and the use of antibiotics globally and how to minimise AMR and the misuse of antibiotics, particularly in low- and middle-income countries.
She is a member of the World Health Organization advisory group on Critically Important Antimicrobials for Human Medicine, is the co-chair for the Impact and Influence committee for the Microbiology Society, and is a mentor for Fleming Fund Fellows based in Eswatini. She is currently co-leading the 'Knocking out AMR' initiative which aims to prioritise solutions to minimise the spread and burden of AMR.
Dr. Catrin Moore’s research focuses on antimicrobial resistance, often termed the silent pandemic, which is on the increase globally, and is worse in many low- and middle-income countries (LMICs). Dr. Moore is a microbiologist and was based at the University of Oxford for nearly 25 years working in the Global and Public health arena. Her work has focussed on building capacity in resource poor settings. Previously based in Laos and Cambodia she built the microbiology laboratory services and research provision in local hospitals.
Dr. Moore joined the Big Data Institute in May 2018, where she led the Global Research on AntiMicrobial Resistance (GRAM) project. Partnered with the Institute for Health Metrics and Evaluation (IHME) in Seattle and Tropical Medicine in Oxford, they analysed global data to produce health metrics and geospatial maps on antimicrobial resistance (AMR). The first ground-breaking publication to estimate the global burden of AMR was published in the Lancet in January 2022.
Dr Moore is a member of the World Health Organization Advisory Group on Critically Important Antimicrobials (AG CIA) for Human Medicine, a mentor for Fleming Fund Fellows based in Eswatini, and a co-chair for the Impact and Influence committee for the Microbiology Society.
Now based at St George’s, University of London she works closely with researchers in several LMICs on the Antimicrobial use (AMU) Data to Inform Antibiotic guidance and Local Action (ADILA) project and other projects focussing on the burden of AMR and antibiotic exposure in the community.
She has work beginning in Uganda to examine the burden of AMR in the community and to understand the data that informs the WHO GLASS surveillance system. She is passionate about reducing the burden of AMR in the community through meaningful, simple, and sustainable interventions such as the use of diagnostic tools, training, and communication in LMICs.